{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:45:26Z","timestamp":1787874326162,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T00:00:00Z","timestamp":1428451200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1245\/s10434-015-4431-5","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T15:04:06Z","timestamp":1428419046000},"page":"4104-4110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette\u2013Guerin Instillation for Non-muscle Invasive Bladder Cancer"],"prefix":"10.1245","volume":"22","author":[{"given":"Hung-Lung","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin P.","family":"Dinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"issue":"4","key":"4431_CR1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212\u201336.","journal-title":"CA Cancer J Clin."},{"issue":"3","key":"4431_CR2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","volume":"56","author":"BW Rhijn van","year":"2009","unstructured":"van Rhijn BW, Burger M, Lotan Y, et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol. 2009;56(3):430\u201342.","journal-title":"Eur Urol."},{"issue":"5","key":"4431_CR3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0022-5347(17)55143-5","volume":"125","author":"NM Heney","year":"1981","unstructured":"Heney NM, Nocks BN, Daly JJ, Blitzer PH, Parkhurst EC. Prognostic factors in carcinoma of the ureter. J Urol. 1981;125(5):632\u2013636.","journal-title":"J Urol."},{"issue":"2","key":"4431_CR4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0022-5347(17)37779-0","volume":"146","author":"R Klan","year":"1991","unstructured":"Klan R, Loy V, Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol. 1991;146(2):316\u20138.","journal-title":"J Urol."},{"issue":"3","key":"4431_CR5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","volume":"170","author":"A Bohle","year":"2003","unstructured":"Bohle A, Brandau S. Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. J Urol. 2003;170(3):964\u20139.","journal-title":"J Urol."},{"key":"4431_CR6","doi-asserted-by":"crossref","unstructured":"Davis JW, Sheth SI, Doviak MJ, Schellhammer PF. Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup. J Urol. 2002;167(2 Pt 1):494\u2013500; discussion 501.","DOI":"10.1097\/00005392-200202000-00011"},{"issue":"17","key":"4431_CR7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","volume":"325","author":"DL Lamm","year":"1991","unstructured":"Lamm DL, Blumenstein BA, Crawford ED, et al. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder. N Engl J Med. 1991;325(17):1205\u20139.","journal-title":"N Engl J Med."},{"key":"4431_CR8","unstructured":"Catalona WJ, Ratliff TL. Bacillus Calmette-Guerin and superficial bladder cancer. Clinical experience and mechanism of action. Surg Ann. 1990;22:363\u201378."},{"issue":"3","key":"4431_CR9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.eururo.2004.05.003","volume":"46","author":"JR Oddens","year":"2004","unstructured":"Oddens JR, van der Meijden AP, Sylvester R. One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe? Eur Urol. 2004;46(3):336-8.","journal-title":"Eur Urol."},{"issue":"2","key":"4431_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/10408360500523878","volume":"43","author":"JM Estrela","year":"2006","unstructured":"Estrela JM, Ortega A, Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci. 2006;43(2):143\u201381.","journal-title":"Crit Rev Clin Lab Sci."},{"issue":"6","key":"4431_CR11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/cbf.1149","volume":"22","author":"GK Balendiran","year":"2004","unstructured":"Balendiran GK, Dabur R, Fraser D. The role of glutathione in cancer. Cell Biochem Funct. 2004;22(6):343\u201352.","journal-title":"Cell Biochem Funct."},{"issue":"3","key":"4431_CR12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jn\/134.3.489","volume":"134","author":"G Wu","year":"2004","unstructured":"Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr. 2004;134(3):489\u201392.","journal-title":"J Nutr."},{"issue":"10","key":"4431_CR13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1158\/1940-6207.CAPR-10-0035","volume":"3","author":"M Chen","year":"2010","unstructured":"Chen M, Hildebrandt MA, Clague J, et al. Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer. Cancer Prev Res (Phila). 2010;3(10):1235\u201345.","journal-title":"Cancer Prev Res (Phila)."},{"key":"4431_CR14","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3027-2","volume-title":"Recursive partitioning in the health sciences","author":"H Zhang","year":"1999","unstructured":"Zhang H, Singer B. Recursive partitioning in the health sciences. New York: Springer; 1999."},{"issue":"10","key":"4431_CR15","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/annonc\/mdq212","volume":"21","author":"Z Sun","year":"2010","unstructured":"Sun Z, Chen J, Aakre J, et al. Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients. Ann Oncol. 2010;21(10):2011\u20136.","journal-title":"Ann Oncol."},{"issue":"8","key":"4431_CR16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3727\/096504010X12644422320780","volume":"18","author":"C Paz-y-Mino","year":"2010","unstructured":"Paz-y-Mino C, Munoz MJ, Lopez-Cortes A, et al. Frequency of polymorphisms pro198leu in GPX-1 gene and ile58thr in MnSOD gene in the altitude Ecuadorian population with bladder cancer. Oncol Res. 2010;18(8):395\u2013400.","journal-title":"Oncol Res."},{"issue":"9","key":"4431_CR17","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1089\/ars.2008.2057","volume":"10","author":"S Toppo","year":"2008","unstructured":"Toppo S, Vanin S, Bosello V, Tosatto SC. Evolutionary and structural insights into the multifaceted glutathione peroxidase (Gpx) superfamily. Antioxid Redox Signal. 2008;10(9):1501\u201314.","journal-title":"Antioxid Redox Signal."},{"issue":"4","key":"4431_CR18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.urology.2005.04.033","volume":"66","author":"H Zhao","year":"2005","unstructured":"Zhao H, Liang D, Grossman HB, Wu X. Glutathione peroxidase 1 gene polymorphism and risk of recurrence in patients with superficial bladder cancer. Urology. 2005;66(4):769\u201374.","journal-title":"Urology."},{"issue":"2","key":"4431_CR19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.ju.0000130942.40597.9d","volume":"172","author":"Y Ichimura","year":"2004","unstructured":"Ichimura Y, Habuchi T, Tsuchiya N, et al. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. J Urol. 2004;172(2):728\u201332.","journal-title":"J Urol."},{"issue":"3","key":"4431_CR20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2010.11.031","volume":"59","author":"E Chiong","year":"2011","unstructured":"Chiong E, Kesavan A, Mahendran R, et al. NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Guerin therapy for bladder cancer. Eur Urol. 2011;59(3):430\u20137.","journal-title":"Eur Urol."},{"issue":"2","key":"4431_CR21","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0022-5347(05)64744-1","volume":"168","author":"SH Pook","year":"2002","unstructured":"Pook SH, Esuvaranathan K, Mahendran R. N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized mycobacterium bovis in human bladder cancer cells. J Urol. 2002;168(2):780\u20135.","journal-title":"J Urol."},{"issue":"2","key":"4431_CR22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12263-007-0052-3","volume":"2","author":"G Bermano","year":"2007","unstructured":"Bermano G, Pagmantidis V, Holloway N, et al. Evidence that a polymorphism within the 3\u2032UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer. Genes Nutr. 2007;2(2):225\u201332.","journal-title":"Genes Nutr."},{"issue":"1","key":"4431_CR23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00008571-200401000-00004","volume":"14","author":"B Ning","year":"2004","unstructured":"Ning B, Wang C, Morel F, et al. Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases\/controls and a novel form. Pharmacogenetics. 2004;14(1):35\u201344.","journal-title":"Pharmacogenetics."},{"issue":"2","key":"4431_CR24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-009-0589-5","volume":"121","author":"IE Andonova","year":"2010","unstructured":"Andonova IE, Justenhoven C, Winter S, et al. No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk. Breast Cancer Res Treat. 2010;121(2):497\u2013502.","journal-title":"Breast Cancer Res Treat."},{"issue":"1\u20134","key":"4431_CR25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000056851","volume":"91","author":"E Schnakenberg","year":"2000","unstructured":"Schnakenberg E, Breuer R, Werdin R, Dreikorn K, Schloot W. Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer. Cytogenet Cell Genet. 2000;91(1\u20134):234\u20138.","journal-title":"Cytogenet Cell Genet."},{"issue":"13\u201314","key":"4431_CR26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/15287390801988087","volume":"71","author":"K Golka","year":"2008","unstructured":"Golka K, Schmidt T, Seidel T, et al. The influence of polymorphisms of glutathione S-transferases M1 and M3 on the development of human urothelial cancer. J Toxicol Environ Health A. 2008;71(13\u201314):881\u20136.","journal-title":"J Toxicol Environ Health A."},{"issue":"2","key":"4431_CR27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10549-009-0585-9","volume":"121","author":"KD Yu","year":"2010","unstructured":"Yu KD, Fan L, Di GH, et al. Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1. Breast Cancer Res Treat. 2010;121(2):485\u201396.","journal-title":"Breast Cancer Res Treat."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4431-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-015-4431-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4431-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T02:22:42Z","timestamp":1566526962000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-015-4431-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,8]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["4431"],"URL":"https:\/\/doi.org\/10.1245\/s10434-015-4431-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,8]]}}}